111 filings
Page 2 of 6
8-K
1ezxi472aw0
3 Aug 22
Departure of Directors or Certain Officers
4:10pm
8-K
njrlj
22 Jun 22
Departure of Directors or Certain Officers
4:02pm
8-K/A
cwezb4j
1 Jun 22
Changes in Registrant's Certifying Accountant
7:01am
8-K
blpfw fjisla75fej
31 May 22
Other Events
8:51am
8-K
be31q0v891r o88j
10 May 22
Zai Lab Announces First Quarter 2022
4:10pm
8-K/A
mjnlg
2 May 22
Changes in Registrant's Certifying Accountant
4:31pm
8-K
qan9snl
21 Apr 22
Zai Lab Announces Engagement of KPMG LLP, a U.S. Auditor, as the Company’s Independent Registered Public Accounting Firm
7:34am
8-K
4o9 o0a92q
1 Apr 22
Departure of Directors or Certain Officers
4:32pm
8-K
u8tyra3 41wkqecush
28 Mar 22
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
yctgvhq2n9zl l3er8
15 Mar 22
Zai Lab Announces the Appointment of Josh Smiley as Chief Operating Officer
8:31am
8-K
j5ay0frle 81
1 Mar 22
Results of Operations and Financial Condition
4:17pm
8-K
3nq0pjzbd9 qi
6 Jan 22
Zai Lab Announces NDA Acceptance of
7:44am
8-K
v76oy 3ggt
22 Dec 21
Zai Lab announces promotion of Harald Reinhart M.D. to President and Head of Global Development, Neuroscience, Autoimmune and Infectious Diseases
4:14pm
8-K
4jad51hn8sbk
16 Dec 21
China NMPA Approves NUZYRA® as a Category 1
7:43am
8-K
qyu nu195ve
3 Dec 21
Zai Lab Announces Inclusion of ZEJULA® (Niraparib) in China’s National Reimbursement Drug List for First-Line Ovarian Cancer
7:45am
8-K
vfnuzfyazhzuu 5h085
22 Nov 21
Zai Lab Appoints Richard Gaynor, MD, to its Board of Directors
7:40am
8-K
mohr09 uax
9 Nov 21
Zai Lab and Blueprint Medicines Announce Strategic Collaboration and License
4:26pm
8-K
o4mg1
5 Nov 21
Other Events
4:14pm
8-K
lfxyspk7
20 Oct 21
ZL-1102, Zai Lab’s Internally Developed Novel Human
4:06pm
8-K
zynfla8fzukkd1h
19 Oct 21
Zai Lab and Entasis Therapeutics Announce Positive
9:21am